Natriuretic peptides (NPs) are key diagnostic and prognostic biomarkers for patients with
heart failure (HF). The main mechanism for increasing serum NP levels, which is …

The natriuretic peptides are a family of peptides each with a 17 amino acid disulphide ring
structure, but are genetically distinct with diverse actions in cardiovascular, renal, and …

There is evidence that natriuretic peptide (namely atrial and/or B-type natriuretic peptides)
plasma concentration may be elevated in many clinical conditions besides cardiovascular …

Tremendous advances have been made in understanding the pathophysiology and
treatment of congestive heart failure (CHF). However, diagnosis still remains difficult, even …

Background Cardiac natriuretic peptides are activated in heart failure. However, their
diagnostic and prognostic values have not been compared under the routine conditions of …

Natriuretic peptides (NPs) counter the effects of volume overload or adrenergic activation of
the cardiovascular system. They are able to induce arterial vasodilatations, natriuresis and …

For patients presenting with acute dyspnea, an incorrect diagnosis could increase the
mortality risk. When used in the evaluation of patients with acute symptoms, brain natriuretic …

Background: Natriuretic peptides are currently used in the diagnosis and follow‐up of
patients with Chronic Heart Failure (CHF). However, it is unknown whether there are …

Aims N‐ANP, N‐BNP and BNP are proven to be excellent markers for diagnosis and the
prediction of outcome in heart failure patients. Published studies on this subject differ in …

Background: Plasma natriuretic peptide levels may be useful in the diagnosis of heart
failure. The available natriuretic peptide assays differ markedly in their performance …